ArticleJournal of evidence-based medicine2026
Guidance for Grading the Evidence in Quantitative Umbrella Reviews.
Article in Journal of evidence-based medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUmbrella reviews (URs) synthesize evidence across multiple systematic reviews and meta-analyses to inform decision-making. However, evaluating and integrating evidence certainty across overlapping and sometimes conflicting meta-analyses remains a major methodological challenge of URs, limiting the reliability of conclusions.
objectiveTo compare evidence evaluation frameworks for URs, assess their suitability for different study types, and provide guidance for managing overlapping evidence, conflicting certainty ratings, and forming overall conclusions.
methodsWe mapped published UR methods to identify current practices and gaps. Frameworks were compared across three dimensions: applicability to study types (interventional, causal observational, and descriptive observational), scalability and reproducibility, and capacity to handle methodological challenges specific to URs. Recommendations were developed through expert consensus and validated via case studies across diverse domains.
resultsGrading of Recommendations Assessment, Development and Evaluation (GRADE) is widely accepted for interventional evidence but shows limited applicability for observational URs due to subjective judgments and reproducibility issues. Credibility frameworks, based on predefined statistical thresholds, offer greater scalability and reproducibility but require adaptation for different study types. Key challenges include: (1) managing overlapping primary studies, (2) resolving conflicting certainty ratings between high-quality reviews, and (3) ensuring transparent evidence integration.
conclusionsFramework selection should be tailored to study type and context, with credibility frameworks better suited for observational evidence and GRADE optimal for interventional studies. Systematic approaches to overlapping evidence and conflicting ratings are essential for UR validity. We provide practical recommendations for framework selection, strategies for common challenges, and enhanced reporting standards to improve transparency and reproducibility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.